about
Role of Akt signaling in resistance to DNA-targeted therapyHuman concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake.Gemcitabine eliminates double minute chromosomes from human ovarian cancer cellsMultifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cellsSolitary cerebral metastasis from transitional cell carcinoma after a 14-year remission of urinary bladder cancer treated with gemcitabine: Case report and literature review.Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation.Small molecule inhibitor of the RPA70 N-terminal protein interaction domain discovered using in silico and in vitro methods.Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population.BOOP as a rare complication of gemcitabine therapySynergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy.Antimetabolite Treatment for Pancreatic Cancer.Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells.Application of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy.Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51.Evaluation of platinum chemotherapy in combination with HER2-targeted α-particle radiationOutpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.Metastatic brain tumor from urothelial carcinoma of the prostatic urethra.Expression levels of ERCC1 and RRM1 mRNA and clinical outcome of advanced non-small cell lung cancerTowards tailored therapy of glioblastoma multiforme.Pharmacological factors affecting accumulation of gemcitabine's active metabolite, gemcitabine triphosphate.Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells.Herceptin-conjugated temperature-sensitive immunoliposomes encapsulating gemcitabine for breast cancer.Multifunctional platinum-based nanoparticles for biomedical applications.Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancerMRE11A and SKP2 genes are associated with the increased cytotoxicity induced by the synergistic effects of cisplatin and gemcitabine in bladder cancer cells.Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.Synthesis and cytostatic evaluation of 4-N-alkanoyl and 4-N-alkyl gemcitabine analogues.Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.Fixed-dose-rate administration of gemcitabine in cancer-bearing cats: A pilot study.Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR.Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine.S-phase cell-specific modification by gemcitabine of PFGE-analyzed radiation-induced DNA fragmentation and rejoining.The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro.
P2860
Q28066950-A6C9F452-86A8-4528-91FF-B4A30017FAC7Q28486221-A5B055F9-7BFF-461B-B6FB-63F8899A6FD6Q28535582-84F663FE-AE0E-4FCE-8BA1-A1420B6BF33AQ30405605-464148AC-1C72-4C32-8357-AD0CE6880059Q30560260-4AA08C31-9B40-4CF7-AB1D-9E58896D0727Q33761140-C1C3C585-257E-4DEE-8974-2D0A8C60362EQ33860865-2AE2CF2B-6806-4C83-80AA-1D1B28C23A88Q34778035-64B0E49D-4AF5-4185-8601-E5469CCD139BQ35127260-899B1863-B28E-4A4E-9EA5-5212DB5F10C5Q35653164-D880F810-42D3-4AEF-9490-B343BFA77242Q35826334-F68048BA-7197-4555-ADCA-9862DD4C39E4Q36088727-67E5D828-21A1-4F88-AFCD-4E4DB9853BD5Q36268729-BE7BC818-A36C-4C48-9DC5-800EFCC78398Q36551498-7E807E9B-E15D-4706-8AD9-EC47F81906F0Q36589778-A7BE80B4-2E15-4F12-8724-9ADDFBC20DCDQ36674828-AFEF280C-DD4A-4F3A-8C5A-F87AB81572FFQ37025617-990FE495-CB59-4E5E-A6EF-184EC8A7F897Q37038352-9188D7B8-4A0B-49FB-A1EE-612B05B929E9Q37126129-3580D2D9-F3BE-4B26-8B27-59F307A64763Q37382706-34D2DB24-43A8-402C-B65F-E1A89937D21BQ37908815-6DDBCB41-9C2C-4A10-808B-671F763AFF96Q38673319-AB9666B8-3243-41CE-AC75-C53B42AF8299Q38787316-C0E4E786-33B2-450B-9B24-C12B61280CEBQ38802097-2A969A96-255D-41E0-A67B-20B159E1FAD7Q38812240-95004127-806F-4B45-8D03-7C1E1CA8323AQ38878964-0BE6DFFB-FCA9-47C3-9F33-8EDD9FE3B867Q39005742-36156842-B22D-4CAA-9BB5-E308B15E6265Q39013393-619249C1-EF0F-4A31-A6F6-D9E08A6A99E0Q39014487-FDF6B3A6-9616-4112-AF9B-35E994059D31Q39018240-476BBA04-653F-4950-B202-A78DE52877E6Q39042999-1E054871-2070-40E7-A8A1-AAE3129BD373Q39110541-198A916F-3077-44A8-B36A-B59C0802C0B7Q39222400-E79D93CC-8A07-42A5-AEA9-FC101D5F5FD5Q39262247-1447BED6-0FE8-4F97-911A-5C064D013C3AQ39295094-62039833-7887-44BE-9A58-B2610780305FQ39434645-6205552C-519C-41DA-A38C-FC32E9238493Q39668803-783CD41A-6C68-4718-9949-806B56966433Q39691306-A093A61E-EB49-470B-9C51-C76CFCDB82CFQ39935069-8828BCCF-B8A2-4F23-B2AE-67A4C1AA4245Q39956742-230D9D7F-84EE-44C8-BF33-80A9EB197D79
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of gemcitabine in cancer therapy.
@ast
Role of gemcitabine in cancer therapy.
@en
type
label
Role of gemcitabine in cancer therapy.
@ast
Role of gemcitabine in cancer therapy.
@en
prefLabel
Role of gemcitabine in cancer therapy.
@ast
Role of gemcitabine in cancer therapy.
@en
P2093
P2860
P356
P1433
P1476
Role of gemcitabine in cancer therapy.
@en
P2093
G Finocchiaro
S Bartolini
P2860
P356
10.1517/14796694.1.1.7
P407
P577
2005-02-01T00:00:00Z